Yahong Pharmaceutical: Net loss of 162 million yuan in the first half of 2025.

Aihong Pharmaceuticals announced that its operating income in the first half of 2025 was 130 million yuan, a year-on-year increase of 61.80%. The net loss attributable to shareholders of the listed company was 162 million yuan, compared to a loss of 184 million yuan in the same period of the previous year.